These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29107992)

  • 21. Personalized
    Del Prete M; Buteau FA; Arsenault F; Saighi N; Bouchard LO; Beaulieu A; Beauregard JM
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):728-742. PubMed ID: 30506283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
    Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C
    Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in (177)Lu-DOTATATE peptide receptor radionuclide therapy.
    Brolin G; Gustafsson J; Ljungberg M; Gleisner KS
    Phys Med Biol; 2015 Aug; 60(15):6131-49. PubMed ID: 26215085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
    J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.
    Baechler S; Hobbs RF; Boubaker A; Buchegger F; He B; Frey EC; Sgouros G
    Med Phys; 2012 Oct; 39(10):6118-28. PubMed ID: 23039651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between 2D and 3D dosimetry protocols in 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma.
    Assié K; Dieudonné A; Gardin I; Buvat I; Tilly H; Vera P
    Cancer Biother Radiopharm; 2008 Feb; 23(1):53-64. PubMed ID: 18298329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of commercial dosimetric software platforms in patients treated with
    Mora-Ramirez E; Santoro L; Cassol E; Ocampo-Ramos JC; Clayton N; Kayal G; Chouaf S; Trauchessec D; Pouget JP; Kotzki PO; Deshayes E; Bardiès M
    Med Phys; 2020 Sep; 47(9):4602-4615. PubMed ID: 32632928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA
    Gosewisch A; Delker A; Tattenberg S; Ilhan H; Todica A; Brosch J; Vomacka L; Brunegraf A; Gildehaus FJ; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2018 Aug; 8(1):76. PubMed ID: 30076556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4D SPECT/CT acquisition for 3D dose calculation and dose planning in (177)Lu-peptide receptor radionuclide therapy: applications for clinical routine.
    Kairemo K; Kangasmäki A
    Recent Results Cancer Res; 2013; 194():537-50. PubMed ID: 22918781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
    Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
    Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT).
    Chicheportiche A; Artoul F; Schwartz A; Grozinsky-Glasberg S; Meirovitz A; Gross DJ; Godefroy J
    EJNMMI Phys; 2018 Jun; 5(1):10. PubMed ID: 29916115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot study.
    Nautiyal A; Jha AK; Mithun S; Shetye B; Kameswaran M; Shah S; Rangarajan V; Gupta S
    Nucl Med Commun; 2021 Dec; 42(12):1382-1395. PubMed ID: 34406146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management.
    Chicheportiche A; Ben-Haim S; Grozinsky-Glasberg S; Oleinikov K; Meirovitz A; Gross DJ; Godefroy J
    EJNMMI Phys; 2020 Jan; 7(1):5. PubMed ID: 31975156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry.
    Li T; Wu NY; Song N; Mok GSP
    Ann Nucl Med; 2018 Jan; 32(1):34-43. PubMed ID: 29143283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate.
    Ezziddin S; Reichmann K; Yong-Hing C; Damm M; Risse J; Ahmadzadehfar H; Logvinski T; Guhlke S; Biersack HJ; Sabet A
    Nuklearmedizin; 2013; 52(5):170-7. PubMed ID: 23963021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution, pharmacokinetics, and organ-level dosimetry for
    Esquinas PL; Shinto A; Kamaleshwaran KK; Joseph J; Celler A
    EJNMMI Phys; 2018 Dec; 5(1):30. PubMed ID: 30523435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different methods for post-therapeutic dosimetry in [
    Rosar F; Schön N; Bohnenberger H; Bartholomä M; Stemler T; Maus S; Khreish F; Ezziddin S; Schaefer-Schuler A
    EJNMMI Phys; 2021 May; 8(1):40. PubMed ID: 33950333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
    Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
    J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized
    Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM
    EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.